-
2
-
-
70449715616
-
Immunophenotypic variations in mantle cell lymphoma
-
Gao J, Peterson L, Nelson B, et al. Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol 2009;132:699-706.
-
(2009)
Am J Clin Pathol
, vol.132
, pp. 699-706
-
-
Gao, J.1
Peterson, L.2
Nelson, B.3
-
3
-
-
0028225201
-
European Lymphoma Task Force (ELTF): Report of the workshop on mantle cell lymphoma (MCL)
-
Zucca E, Stein H, Coifier B. European Lymphoma Task Force (ELTF): report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 1994;5:507-511. (Pubitemid 24223502)
-
(1994)
Annals of Oncology
, vol.5
, Issue.6
, pp. 507-511
-
-
Zucca, E.1
Stein, H.2
Coiffier, B.3
-
4
-
-
34648824397
-
Genetic and molecular pathogenesis of mantle cell lymphoma: Perspectives for new targeted therapeutics
-
DOI 10.1038/nrc2230, PII NRC2230
-
Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007;7:750-762. (Pubitemid 47463673)
-
(2007)
Nature Reviews Cancer
, vol.7
, Issue.10
, pp. 750-762
-
-
Jares, P.1
Colomer, D.2
Campo, E.3
-
5
-
-
77949456210
-
Current treatment standards and emerging strategies in mantle cell lymphoma
-
Dreyling M, Hiddemann W. Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology 2009:1; 542-551.
-
(2009)
Hematology
, vol.1
, pp. 542-551
-
-
Dreyling, M.1
Hiddemann, W.2
-
6
-
-
70349560308
-
How i treat mantle cell lymphoma
-
Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood 2009;114:1469-1476.
-
(2009)
Blood
, vol.114
, pp. 1469-1476
-
-
Ghielmini, M.1
Zucca, E.2
-
7
-
-
0006818262
-
Treatment of mantle-cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response
-
Foran JM, Cunningham D, Coifier B, et al. Treatment of mantle-cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response. Ann Oncol 2000;11:117-121.
-
(2000)
Ann Oncol
, vol.11
, pp. 117-121
-
-
Foran, J.M.1
Cunningham, D.2
Coifier, B.3
-
8
-
-
33750625445
-
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma
-
DOI 10.1200/JCO.2006.07.9665
-
Fisher RI, Bernstein SH, Kahl BS, et al. Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol 2006;24:4867-4874. (Pubitemid 46655613)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.30
, pp. 4867-4874
-
-
Fisher, R.I.1
Bernstein, S.H.2
Kahl, B.S.3
Djulbegovic, B.4
Robertson, M.J.5
De Vos, S.6
Epner, E.7
Krishnan, A.8
Leonard, J.P.9
Lonial, S.10
Stadtmauer, E.A.11
O'Connor, O.A.12
Shi, H.13
Boral, A.L.14
Goy, A.15
-
9
-
-
64149112784
-
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma
-
Habermann TM, Lossos IS, Justice G, et al. Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma. Br J Haematol 2009;145:344-349.
-
(2009)
Br J Haematol
, vol.145
, pp. 344-349
-
-
Habermann, T.M.1
Lossos, I.S.2
Justice, G.3
-
10
-
-
20144388941
-
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: Results of a prospective randomized trial of the European MCL Network
-
DOI 10.1182/blood-2004-10-3883
-
Dreyling M, Lenz G, Hoster E, et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission signif cantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 2005;105:2677-2684. (Pubitemid 40450320)
-
(2005)
Blood
, vol.105
, Issue.7
, pp. 2677-2684
-
-
Dreyling, M.1
Lenz, G.2
Hoster, E.3
Van Hoof, A.4
Gisselbrecht, C.5
Schmits, R.6
Metzner, B.7
Truemper, L.8
Reiser, M.9
Steinhauer, H.10
Boiron, J.-M.11
Boogaerts, M.A.12
Aldaoud, A.13
Silingardi, V.14
Kluin-Nelemans, H.C.15
Hasford, J.16
Parwaresch, R.17
Unterhalt, M.18
Hiddemann, W.19
-
11
-
-
47349126802
-
Advances in the understanding of mantle cell lymphoma
-
DOI 10.1111/j.1365-2141.2008.07124.x
-
Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Heamatol 2008;142:149-165. (Pubitemid 351994053)
-
(2008)
British Journal of Haematology
, vol.142
, Issue.2
, pp. 149-165
-
-
Jares, P.1
Campo, E.2
-
12
-
-
66549113998
-
Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): Importance for interactions with the stromal microenvironment and specif c targeting
-
Kurtova AV, Tamayo AT, Ford RJ, et al. Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specif c targeting. Blood 2009;113:4604-4613.
-
(2009)
Blood
, vol.113
, pp. 4604-4613
-
-
Kurtova, A.V.1
Tamayo, A.T.2
Ford, R.J.3
-
13
-
-
78851470309
-
The challenge of the microenvironment in B-cell lymphomas
-
Coupland SE. The challenge of the microenvironment in B-cell lymphomas. Histopathology 2011;58:69-80.
-
(2011)
Histopathology
, vol.58
, pp. 69-80
-
-
Coupland, S.E.1
-
14
-
-
0036065094
-
Establishment and characterization of a new mantle cell lymphoma cell line, Mino
-
DOI 10.1016/S0145-2126(02)00013-9, PII S0145212602000139
-
Lai R, McDonnell TJ, O'Connor SL, et al. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res 2002;26:849-855. (Pubitemid 34778500)
-
(2002)
Leukemia Research
, vol.26
, Issue.9
, pp. 849-855
-
-
Lai, R.1
McDonnell, T.J.2
O'Connor, S.L.3
Medeiros, L.J.4
Oudat, R.5
Keating, M.6
Morgan, M.B.7
Curiel, T.J.8
Ford, R.J.9
-
15
-
-
9944243557
-
Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519
-
Rudolpha C, Steinemanna D, von Neuhof a N, et al. Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. Cancer Genet Cytogenet 2004;153:144-150.
-
(2004)
Cancer Genet Cytogenet
, vol.153
, pp. 144-150
-
-
Rudolpha, C.1
Steinemanna, D.2
Von Neuhofa, N.3
-
16
-
-
7344236837
-
Establishment and characterization of a mantle cell lymphoma cell line
-
DOI 10.1046/j.1365-2141.1998.00911.x
-
Jeon HJ, Kim CW, Yoshino T, et al. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol 1998;102:1323-1326. (Pubitemid 28435219)
-
(1998)
British Journal of Haematology
, vol.102
, Issue.5
, pp. 1323-1326
-
-
Jeon, H.O.J.1
Kim, C.W.2
Yoshino, T.3
Akagi, T.4
-
18
-
-
0023219823
-
Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells
-
Joshi SS, Sharp JG, Brunson KW. Dif erential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells. Oncology 1987;44:180-185. (Pubitemid 17103284)
-
(1987)
Oncology
, vol.44
, Issue.3
, pp. 180-185
-
-
Joshi, S.S.1
Sharp, J.G.2
Brunson, K.W.3
-
20
-
-
34848829606
-
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38-expressing B-cell chronic lymphocytic leukemia
-
DOI 10.1158/1078-0432.CCR-07-0283
-
Joshi AD, Hegde GV, Dickinson JD, et al. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Clin Cancer Res 2007;13:5295-5304. (Pubitemid 47510353)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.18
, pp. 5295-5304
-
-
Joshi, A.D.1
Hegde, G.V.2
Dickinson, J.D.3
Mittal, A.K.4
Lynch, J.C.5
Eudy, J.D.6
Armitage, J.O.7
Bierman, P.J.8
Bociek, R.G.9
Devetten, M.P.10
Vose, J.M.11
Joshi, S.S.12
-
21
-
-
0035942271
-
Significance analysis of microarrays applied to the ionizing radiation response
-
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2004;98:5116-5121.
-
(2004)
Proc Natl Acad Sci USA
, vol.98
, pp. 5116-5121
-
-
Tusher, V.G.1
Tibshirani, R.2
Chu, G.3
-
22
-
-
27344435774
-
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
-
DOI 10.1073/pnas.0506580102
-
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression prof les. Proc Natl Acad Sci USA 2005;102:15545-15550. (Pubitemid 41528093)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.43
, pp. 15545-15550
-
-
Subramanian, A.1
Tamayo, P.2
Mootha, V.K.3
Mukherjee, S.4
Ebert, B.L.5
Gillette, M.A.6
Paulovich, A.7
Pomeroy, S.L.8
Golub, T.R.9
Lander, E.S.10
Mesirov, J.P.11
-
23
-
-
84867870598
-
Novel therapy for therapy-resistant mantle cell lymphoma: Multipronged approach with targeting hedgehog signalling
-
Apr 17. [Epub ahead of print]
-
Hegde GV, Nordgren TM, Munger CM, et al. Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting hedgehog signalling. Int J Cancer 2012 Apr 17. [Epub ahead of print]
-
(2012)
Int J Cancer
-
-
Hegde, G.V.1
Nordgren, T.M.2
Munger, C.M.3
-
24
-
-
65349178165
-
Marginal zone variant of mantle cell lymphoma: CD5-negative cyclin D1-positive variant posing a diagnostic dilemma
-
Golardi N, Velasco MR, Elghetany MT. Marginal zone variant of mantle cell lymphoma: CD5-negative cyclin D1-positive variant posing a diagnostic dilemma. Pathol Int 2009;59:317-321.
-
(2009)
Pathol Int
, vol.59
, pp. 317-321
-
-
Golardi, N.1
Velasco, M.R.2
Elghetany, M.T.3
-
25
-
-
77955906947
-
An uncommon case of de novo CD10 + CD5-mantle cell lymphoma mimics follicle center B cell lymphoma
-
Zapata M, Budnick SD, Bordoni R, et al. An uncommon case of de novo CD10 + CD5-mantle cell lymphoma mimics follicle center B cell lymphoma. Int J Clin Exp Pathol 2010;3:430-436.
-
(2010)
Int J Clin Exp Pathol
, vol.3
, pp. 430-436
-
-
Zapata, M.1
Budnick, S.D.2
Bordoni, R.3
-
26
-
-
0033041288
-
3+ follicular lymphomas
-
Lai R, Weiss LM, Chang KL, et al. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43 + follicular lymphomas. Am J Clin Pathol 1999;111:488-494. (Pubitemid 29153144)
-
(1999)
American Journal of Clinical Pathology
, vol.111
, Issue.4
, pp. 488-494
-
-
Lai, R.1
Weiss, L.M.2
Chang, K.L.3
Arber, D.A.4
-
27
-
-
0242300576
-
CD23 expression in mantle cell lymphoma: Clinicopathologic features of 18 cases
-
DOI 10.1309/0UM2-V45M-00M6-9XPX
-
Schlette E, Fu K, Medeiros LJ. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol 2003;120:760-766. (Pubitemid 37339685)
-
(2003)
American Journal of Clinical Pathology
, vol.120
, Issue.5
, pp. 760-766
-
-
Schlette, E.1
Fu, K.2
Medeiros, L.J.3
-
28
-
-
21444452190
-
FGF7-like gene is associated with pericentric inversion of chromosome 9, and FGF7 is involved in the development of ovarian cancer
-
Yasuhara T, Okamoto A, Kitagawa T, et al. FGF7-like gene is associated with pericentric inversion of chromosome 9, and FGF7 is involved in the development of ovarian cancer. Int J Oncol 2005;26:1209-1216.
-
(2005)
Int J Oncol
, vol.26
, pp. 1209-1216
-
-
Yasuhara, T.1
Okamoto, A.2
Kitagawa, T.3
-
29
-
-
0037678639
-
Cytogenetic study of malignant triton tumor: A case report
-
DOI 10.1016/S0165-4608(02)00935-4
-
Haddadin MH, Hawkins AL, Long P, et al. Cytogenetic study of malignant triton tumor: a case report. Cancer Genet Cytogenet 2003;144:100-105. (Pubitemid 36808955)
-
(2003)
Cancer Genetics and Cytogenetics
, vol.144
, Issue.2
, pp. 100-105
-
-
Haddadin, M.H.1
Hawkins, A.L.2
Long, P.3
Morsberger, L.A.4
Depew, D.5
Epstein, J.I.6
Griffin, C.A.7
-
30
-
-
18744421982
-
Chromosomal and gene amplification in diffuse large B-cell lymphoma
-
Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplif cation in diffuse large B-cell lymphoma. Blood 1998;92:234-240. (Pubitemid 28303198)
-
(1998)
Blood
, vol.92
, Issue.1
, pp. 234-240
-
-
Rao, P.H.1
Houldsworth, J.2
Dyomina, K.3
Parsa, N.Z.4
Cigudosa, J.C.5
Louie, D.C.6
Popplewell, L.7
Offit, K.8
Jhanwar, S.C.9
Chaganti, R.S.K.10
-
31
-
-
33744832429
-
Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines
-
DOI 10.1016/j.leukres.2005.11.013, PII S0145212605004388
-
Camps J, Salaverria I, Garcia MJ, et al. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res 2006;30:923-934. (Pubitemid 43831180)
-
(2006)
Leukemia Research
, vol.30
, Issue.8
, pp. 923-934
-
-
Camps, J.1
Salaverria, I.2
Garcia, M.J.3
Prat, E.4
Bea, S.5
Pole, J.C.6
Hernandez, L.7
Rey, J.D.8
Cigudosa, J.C.9
Bernues, M.10
Caldas, C.11
Colomer, D.12
Miro, R.13
Campo, E.14
-
32
-
-
18744408734
-
Mantle cell lymphoma with 8q24 chromosomal abnormalities: A report of 5 cases with blastoid features
-
DOI 10.1097/01.MP.0000037310.82136.99
-
Hao S, Sanger W, Onciu M, et al. Mantle cell lymphoma with 8q24 chromosomal abnormalities : a report of 5 cases with blastoid features. Mod Pathol 2002;15:1266-1272. (Pubitemid 35462993)
-
(2002)
Modern Pathology
, vol.15
, Issue.12
, pp. 1266-1272
-
-
Hao, S.1
Sanger, W.2
Onciu, M.3
Lai, R.4
Schlette, E.J.5
Medeiros, L.J.6
-
33
-
-
77951003346
-
MicroRNA expression prof le and identif cation of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma
-
Zhao JJ, Lin J, Lwin T, et al. MicroRNA expression prof le and identif cation of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010;115:2630-2639.
-
(2010)
Blood
, vol.115
, pp. 2630-2639
-
-
Zhao, J.J.1
Lin, J.2
Lwin, T.3
-
34
-
-
47049120287
-
Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas
-
Wlodarska I, Dierickx D, Vanhentenrijk V, et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 2008;111:5683-5690.
-
(2008)
Blood
, vol.111
, pp. 5683-5690
-
-
Wlodarska, I.1
Dierickx, D.2
Vanhentenrijk, V.3
-
35
-
-
79956125740
-
Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma
-
Enjuanes A, Fernandez V, Hernandez L, et al. Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma. PLoS One 2011;6:e19736.
-
(2011)
PLoS One
, vol.6
-
-
Enjuanes, A.1
Fernandez, V.2
Hernandez, L.3
-
36
-
-
34547691659
-
Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle cell lymphomas
-
DOI 10.3324/haematol.10337
-
Ripperger T, von Neuhof N, Kamphues K, et al. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle cell lymphomas. Haematologica 2007;92:460-468. (Pubitemid 350144291)
-
(2007)
Haematologica
, vol.92
, Issue.4
, pp. 460-468
-
-
Ripperger, T.1
Von Neuhoff, N.2
Kamphues, K.3
Emura, M.4
Lehmann, U.5
Tauscher, M.6
Schraders, M.7
Groenen, P.8
Skawran, B.9
Rudolph, C.10
Callet-Bauchu, E.11
Van Krieken, J.H.J.M.12
Schlegelberger, B.13
Steinemann, D.14
-
37
-
-
77956525903
-
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma
-
Leshchenko V, Kuo P, Shaknovich R, et al. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood 2010;116:1025-1034.
-
(2010)
Blood
, vol.116
, pp. 1025-1034
-
-
Leshchenko, V.1
Kuo, P.2
Shaknovich, R.3
|